(Q48075478)

8 February 2018

editorial

0 references

title

Prediction of treatment outcomes in major depressive disorder (English)

1 reference

8 February 2018

author

Boadie W Dunlop

series ordinal

1

1 reference

8 February 2018

language of work or name

English

0 references

publication date

4 August 2015

1 reference

8 February 2018

Expert Review of Clinical Pharmacology

published in

1 reference

8 February 2018

volume

8

1 reference

8 February 2018

issue

6

1 reference

8 February 2018

page(s)

669-672

1 reference

8 February 2018

A new initiative on precision medicine

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Personalized medicine for depression: can we match patients with treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Prognostic subgroups for citalopram response in the STAR*D trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Serotonin and emotional processing: does it help explain antidepressant drug action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Treatment of depression with atypical features: a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Discovering endophenotypes for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Are there meaningful biomarkers of treatment response for depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Toward a neuroimaging treatment selection biomarker for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Pretreatment brain states identify likely nonresponse to standard treatments for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1075390

10.1586/17512433.2015.1075390

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018